Shicheng Su

19PUBLICATIONS
80CO-AUTHORS
Molecular targetsEpidemiological modellingMedical molecular engineering of nucleic acids and proteinsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 24, 2026
Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy.

|May 11, 2026
Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12.

|Sep 30, 2025
Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responses.

Xiaoqian Zhang, Penghan Huang, Huiping Chen

|Aug 22, 2025
The coming era of proteomics-driven precision medicine.

Ying Jiang, Jian Wang, Aihua Sun

|Jul 25, 2025
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by BRCA1 mutation.

Jingxin Liu, Cai Zhao, Jiahao Chen

|Nov 01, 2024
Beneath the Surface: Neoantigens beyond Chromosomal DNA Mutations.

Shicheng Su

Pageof 4

Frequent Collaborators

9 joint publications

Erwei Song

4 joint publications

Qiang Liu

4 joint publications

Xinwei Liu

3 joint publications

Mengfeng Li